Roles of efflux pumps and nitroreductases in metronidazole-resistant Trichomonas vaginalis
Authors:
Open Access
- 12 February 2025
- journal article
- research article
- Published by Springer Nature in Parasitology Research
- Vol. 124 (2) , 1-13
Abstract
Trichomonas v aginalis infections significantly impact public health and are associated with increased likelihood of HIV infection, prostate cancer, and pregnancy complications. Current treatment relies almost exclusively on 5-nitroimidazoles, particularly metronidazole, raising concerns about drug resistance and treatment efficacy. This study is aimed at evaluating the effectiveness of metronidazole and tinidazole on metronidazole-resistant strains of T. vaginalis and at determining whether efflux pump inhibitors could reverse metronidazole resistance. Additionally, the roles of nitroreductases in metronidazole resistance were also studied. Metronidazole and tinidazole were tested on both metronidazole-sensitive and -resistant T. vaginalis strains. A checkerboard assay was conducted to assess the potential synergy between metronidazole or tinidazole and efflux pump inhibitors. Nitroreductase activity and ferric iron reduction assays were employed to study the functions of nitroreductases. Tinidazole demonstrated better effectiveness against metronidazole-resistant strains compared to metronidazole, with lower minimal lethal concentration levels. However, the tested efflux pump inhibitors did not significantly enhance the efficacy of metronidazole or tinidazole. Pyrimethamine showed some activity but did not improve the efficacy of the 5-nitroimidazoles in combination. Investigations into the role of nitroreductases and other enzymes in metronidazole resistance revealed no clear downregulation trend in resistant strains. Notably, nitroreductase 8 was capable of reducing ferric iron. While tinidazole remains a viable alternative for treating metronidazole-resistant T. vaginalis, efflux pump inhibitors do not effectively reverse resistance. The identification of nitroreductase’s 8 iron-reducing activity suggests its involvement in metronidazole resistance mechanisms. This finding highlights the need for continued research to develop new treatment strategies and improve the management of trichomoniasis, ultimately reducing its public health burden.Keywords
Funding Information
- Austrian Science Fund (P 35545, P 35545, P 35545, P 35545)
- Medical University of Vienna
This publication has 68 references indexed in Scilit:
- Characterization of the components of the thioredoxin system in Bacteroides fragilis and evaluation of its activity during oxidative stressAnaerobe, 2022
- A reassessment of the role of oxygen scavenging enzymes in the emergence of metronidazole resistance in trichomonadsInternational Journal for Parasitology: Drugs and Drug Resistance, 2021
- The effect of iron on metronidazole activity against Trichomonas vaginalis in vitroExperimental Parasitology, 2017
- Adverse Event Profile of Pyrimethamine-Based Therapy in Toxoplasmosis: A Systematic ReviewDrugs in R&D, 2017
- Data Analysis2016
- Hydrogen peroxide is a product of oxygen consumption byTrichomonas vaginalisJournal of Biosciences, 1999
- Analysis of a single-domain P-glycoprotein-like gene in the early-diverging protist Trichomonas vaginalisMolecular and Biochemical Parasitology, 1994
- The purification and properties of two soluble reduced nicotinamide: acceptor oxidoreductases from Trichomonas vaginalisMolecular and Biochemical Parasitology, 1988
- Ferredoxin-dependent reduction of nitroimidazole derivatives in drug-resistant and susceptible strains of trichomonas vaginalisBiochemical Pharmacology, 1986
- Metronidazole-resistant clinical isolates of Trichomonas vaginalis have lowered oxygen affinitiesMolecular and Biochemical Parasitology, 1986